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Abstract
Background: MicroRNAs (miRNAs) are short non-coding RNAs that inhibit translation of target genes by binding to
their mRNAs. The expression of numerous brain-specific miRNAs with a high degree of temporal and spatial
specificity suggests that miRNAs play an important role in gene regulation in health and disease. Here we
investigate the time course gene expression profile of miR-1, -16, and -206 in mouse dorsal root ganglion (DRG),
and spinal cord dorsal horn under inflammatory and neuropathic pain conditions as well as following acute
noxious stimulation.
Results: Quantitative real-time polymerase chain reaction analyses showed that the mature form of miR-1, -16 and
-206, is expressed in DRG and the dorsal horn of the spinal cord. Moreover, CFA-induced inflammation significantly
reduced miRs-1 and -16 expression in DRG whereas miR-206 was downregulated in a time dependent manner.
Conversely, in the spinal dorsal horn all three miRNAs monitored were upregulated. After sciatic nerve partial
ligation, miR-1 and -206 were downregulated in DRG with no change in the spinal dorsal horn. On the other hand,
axotomy increases the relative expression of miR-1, -16, and 206 in a time-dependent fashion while in the dorsal
horn there was a significant downregulation of miR-1. Acute noxious stimulation with capsaicin also increased the
expression of miR-1 and -16 in DRG cells but, on the other hand, in the spinal dorsal horn only a high dose of
capsaicin was able to downregulate miR-206 expression.
Conclusions: Our results indicate that miRNAs may participate in the regulatory mechanisms of genes associated
with the pathophysiology of chronic pain as well as the nociceptive processing following acute noxious
stimulation. We found substantial evidence that miRNAs are differentially regulated in DRG and the dorsal horn of
the spinal cord under different pain states. Therefore, miRNA expression in the nociceptive system shows not only
temporal and spatial specificity but is also stimulus-dependent.
Background
MicroRNAs (miRNAs) are endogenously expressed
short non-coding RNAs thought to inhibit protein trans-
lation through binding to a target complementary
mRNA [1-6]. Thus, the encoded genetic information is
not only transcribed and translated into proteins but
also regulates these processes through miRNA
sequence-guided interactions with the related miRNA
[2,7-9]. Expression analysis of miRNAs has been widely
used to monitor tissue-specific miRNA expression and
regulatory changes in developmental stages, cell types
and tissues [1,10,11]. Tissue and temporal specificity
s u g g e s tt h a tm i R N A ss e q u e n c e sh a v ea no r g a na n d / o r
cell type-specific function [12-16]. Furthermore, abnor-
mal patterns of miRNA expression have also been found
in many disease states where both increased and
decreased expression of miRNAs have been described
[16,17]. The first experimental reports addressing the
involvement of miRNAs in the nociceptive system
clearly indicate that inflammatory muscle pain [18], and
peripheral nerve injury [19] modify the expression pro-
file of a number of miRNAs in trigeminal and dorsal
root ganglion, respectively. A recent work provided evi-
dence that miRNAs regulate the expression of several
transcripts associated with inflammatory pain [20].
Indeed, the nociceptive system is substantially modified
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the nervous system where changes in gene expression
patterns are a marked molecular mechanism underlying
the development and maintenance of chronic pain
[21-25]. Hence, transcriptional changes can dramatically
alter the phenotypic profile and function of neurons and
glia cells in the dorsal root ganglion and spinal cord
dorsal horn, where nociceptive messages are primarily
released to the central nervous system [21,22]. However,
our understanding on the mechanisms regulating post-
transcriptional machinery remains very limited. In the
present study we tested the hypothesis that in addition
to temporal or spatial-specificity miRNA expression is
also stimulus-dependent in the nociceptive system. In
the present study the criteria to select four miRNAs
were their reported expression in the mouse nervous
system [10,26] and/or their predicted pain-related target
genes, such as brain-derived neurotrophic factor, mito-
gen activated protein kinase, phospholipase A2, and
opioid receptor from in silico investigation [27,28].
Therefore, we investigated the temporal, spatial and sti-
mulus-dependent specificity of miRNAs by monitoring
the time-course expression of miR-1, miR-16, miR-122a,
and miR-206 in mouse DRG and spinal cord dorsal
horn under inflammatory and neuropathic pain states as
well as after acute nociceptive stimulation.
Methods
Animals
A d u l tB a l b / cm i c e( 2 0 - 2 5g )w e r eh o u s e d4 - 5p e rc a g e
on a 12 hours light/dark cycles (lights on at 6 A.M.) and
kept at 25°C ± 1°C. Food and water were available
ad libitum. Behavioral experiments were performed
between 9 A.M. and 4 P.M. The experimental proce-
dures performed on animals were approved by the Ethi-
cal Committee for Animal Experimentation of Ribeirão
Preto School of Medicine, University of São Paulo and
followed the International Association for the Study of
Pain guidelines for investigations of experimental pain
in conscious animals [29].
Chronic inflammatory pain model
Tissue inflammation was produced by injecting 20 μLo f
CFA-complete Freund’s adjuvant (Sigma, St. Louis, MO)
subcutaneously in the dorsal aspect of the left hind-paw
whereas mineral oil (Sigma) was used as control. Paw
withdrawal thresholds to mechanical stimuli were
assessed 12 h, 1, 3 and 7 days post-injection. At the
completion of behavioral testing, mice were euthanized.
Control animals were euthanized 12 h post-injection.
Neuropathic pain model
N e r v ei n j u r yw a sp e r f o r m e di na n e s t h e t i z e dm i c e
(ketamine and xylazine, 60 and 8 mg/kg, respectively)
by tying a tight ligature with 8-0 silk wire around
approximately one-third to one-half of the diameter of
the left sciatic nerve [30]. Sham-operated animals had
the left sciatic nerve exposed, but not ligated. After
surgery nerve-injured animals were randomly sepa-
rated in 4 groups and the development of tactile sti-
mulus-induced neuropathic pain hypersensitivity was
assessed at 1, 3, 7 and 14 days post-injury. By the end
of the behavioral assay, mice were euthanized. Sham-
operated control animals were euthanized 12 h post-
injection.
Axotomy
Animals were anesthetizedw i t hk e t a m i n e( 6 0m g / k g )
and xylazine (8 mg/kg), and had the left sciatic nerve
transected. A segment of approximately 1 mm was
removed and the stumps were tightly ligated with 8-0
silk wire. Sham-operated animals had the sciatic nerve
exposed but not sectioned. Nerve-injuried animals were
separated in 3 groups and euthanized 1, 3, and 7 days
post-lesion. Sham-operated animals were killed 24 hours
after surgery. The left L4-L5 DRG and lumbar spinal
dorsal horn were harvested immediately after euthanasia
and processed for total RNA extraction.
Acute noxious stimulation
Acute pain was induced by subcutaneous injection of
capsaicin in the dorsal aspect of the left hindpaw. Two
doses of capsaicin were tested, 2 and 10 μg/20 μL. Con-
trol animals were injected with vehicle (89.5% saline,
10% ethanol, 0.5% Tween-80). Animals were euthanized
10 minutes post injection and DRG and the lumbar
spinal cord dorsal horn dissected out for RNA
extraction.
Behavior analysis
Mechanical hypersensitivity was assessed before and
a f t e rt h ei n j e c t i o no fC F Ao rn e r v ei n j u r yb ym e a s u r i n g
the paw withdrawal threshold in response to probing
calibrated Semmes-Weinstein monofilaments (von Frey
hairs; Stoelting, Wood Dale, IL). Animals were placed
on an elevated meshed grid which allowed full access to
the ventral aspect of the hindpaws. A logarithmic series
of 9 filaments were applied to the left hindpaw to deter-
mine the threshold stiffness required for 50% paw with-
drawal according to the non-parametric method of
Dixon [31] as described by Chaplan et al. [32]. This
behavioral analysis ensured that all animals selected to
the miRNA expression assay developed mechanical
hypersensitivity over the entire period of investigation in
the inflammatory and neuropathic pain models. In the
acute pain model, nocifensive behavior was monitored
as time spent biting/licking capsaicin or vehicle-injected
paw for 10 min.
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Animals were euthanized by cervical dislocation and the
left DRG (L4-L5) as well as the lumbar (L4-L6) spinal
cord were dissected out. Next, the spinal cord was
further dissected in PBS (4°C) by removing only the left
superior quadrant of the spinal cord. Then, the tissues
were rapidly homogenized in Trizol reagent at 4°C and
frozen at -80°C for further processing.
Multiplexing reverse transcriptase reaction
Total RNA from DRG and the dorsal horn of the spinal
cord was isolated using Trizol
® reagent (Invitrogen)
according to the manufacture’s instruction. RNA quality
and quantity were assessed using a spectrophotometer
(Eppendorf BioPhotometer plus). For multiplexing
reverse transcriptase reactions we used TaqMan micro-
RNA Reverse Transcription kit with specific primers for
miR-1, -16, -122a, -206, and snoR-202 following proto-
col provided by the manufacture (Applied Biosystems).
Real-time RT-PCR
To quantify miRNAs by real-time RT- PCR we used Taq-
Man
® Universal PCR Master Mix, No AmpErase
® UNG
(Applied Biosystems). Amplification was performed
according to the manufacture’s standard protocol. PCR
primers and probes for amplification of the mouse
mature miRNAs were specifically design for miR-1, -16,
-122a, -206, and snoR-202 (Applied Biosystems). RT-
PCR analysis was performed on an ABI5500HT instru-
ment (ABI Inc.). All reactions were run in duplicate. The
relative quantity of each miRNA in the tissues was calcu-
lated using the equation RQ = 2
-ΔΔCT [33]. SnoR-202 was
measured by the same method and remained stable along
the tested time period (data not shown). Therefore,
snoR-202 was used for normalization as the internal con-
trol gene whereas the calibrator was the mean threshold
cycle (CT) value for each control group associated with
their respective pain model.
Results
We first monitored the mechanical sensitivity at differ-
ent times after subcutaneous CFA administration, ensur-
ing that all animals selected to the gene expression
assays developed tactile mechanical hypersensitivity over
the entire period of investigation (Figure 1A). There-
after, we were able to detect miR-1, -16 and -206, but
not miR-122a even after 40 cycles. CFA injection
induced a significant downregulation of miR-1, -16 in
DRG as early as 12 h persisting until 7 days post-injec-
tion (Figure 1B). However, the expression of miR-206
showed an irregular profile being downregulated at days
1 and 7, but returned to normal levels by day 3 post-
injection (Figure 1B). On the contrary, in the dorsal
horn of the spinal cord the expression of miR-1, -16,
and -206 showed a significant increase at day 1, 3 and 7
but not in the initial inflammatory process (Figure 1C).
We next analyzed the detectable levels of the three
miRNAs in DRG and the spinal dorsal horn of animals
submitted to partial ligation of the sciatic nerve. This
Figure 1 Expression profile of mature microRNAs in DRG and
the dorsal horn of the spinal cord during peripheral
inflammation.( A) CFA injection induced mechanical
hypersensitivity 12 hours, 1, 3 and 7 days post-injection (black bars)
compared to the basal values (white bars). Mineral-oil injected mice
showed no threshold changes from day 1 to 7 post-injection. (B)I n
DRG, miR-1 (white bars) and -16 (gray bars) were significantly
downregulated under the entire inflammatory period. However,
miR-206 (black bars) was down regulated only on day 1 and 7 post-
injection. (C) In the spinal dorsal horn there was no change in the
early inflammatory process (12 h post-injection) whereas the relative
expression of miRs-1, -16 and -206 showed a significant increase at
day 1, 3 and 7 post-injection. Bars represent mean ± SEM. # p <
0.001 for CFA injected animals compared to mineral oil injected
mice, n = 6 - 8 per group; Student’s t-test. * p < 0.05, ** p < 0.01,
and *** p < 0.001 for each miRNA of the treated group compared
to mineral-oil injected animals and euthanized 12 h post-injection
(time 0), n = 6-8 per group; Student’s t-test.
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stimulus-induced neuropathic pain hypersensitivity.
Peripheral nerve lesion induced a marked mechanical
allodynia from day 1 to 14 post-injury whereas sham-
operated animals showed no change in mechanical
sensitivity (Figure 2A). The expression profile of miR-1
in DRG showed no change at day 1 after nerve injury
but a significant downregulation at day 3, 7 and 14
post-surgery (Figure 2B). Conversely, miR-16 showed no
difference in the expression level over the entire period
of study. However, the expression pattern of miR-206
was similar to miR-1. A remarkable downregulation was
observed as early as day 1, persisting at days 3, 7 and 14
(Figure 2B). In the spinal cord dorsal horn no change
was observed in the expression profile of any miRNAs
investigated (Figure 2C). It is well characterized that
pain from different origins may induce specific phenoty-
pic changes in DRG and the dorsal horn of the spinal
cord. Then, we used another model of neuropathic pain
by axotomizing the sciatic nerve. Opposite to the results
observed in the partial nerve lesion model, complete
peripheral nerve section induced an upregulation of
miR-1, -16 and -206 in DRG at days 1, 3 and 7 post-
injury (Figure 3A). On the other hand, miR-1 showed a
significant decrease in the spinal dorsal horn from day 1
Figure 2 The effect of partial sciatic nerve ligation on miRNA
expression in DRG and spinal cord dorsal horn.( A) Mice
submitted to nerve lesion developed tactile stimulus-induced
hypersensitivity at 1, 3, 7 and 14 days post-surgery (black bars)
whereas sham-operated animals (white bars) showed no change on
mechanical threshold. (B) In DRG, miR-206 (black bars) was
downregulated at all time points investigated whereas miR-1
reduced relative expression (white bars) occurred only after the day
3 post-surgery. No significant change was detected for miR-16 (gray
bars). (C) In spinal cord dorsal horn, there was no modification in
the expression profile for any miRNA studied. Bars represent mean
± SEM. # p < 0.001 for nerve injured animals compared to sham-
operated mice, n = 6 - 8 per group; Student’s t-test. * p < 0.05, ** p
< 0.01, and *** p < 0.001 for each miRNA expression in nerve
injuried group compared to sham-operated control animals
euthanized 24 h after surgery (time 0), n = 6 - 8 per group,
Student’s t-test.
Figure 3 Expression profile of microRNAs in DRG and spinal
dorsal horn after sciatic nerve axotomy.( A) MiR-1 (white bars)
and -206 (black bars) showed a robust upregulation in the dorsal
root ganglion whereas miR-16 (gray bars) relative expression also
increased, but only on days 1 and 3 post-injury returning to its
normal values on day 7 post-nerve lesion. (B) in the dorsal horn of
the spinal cord, miR-1 was downregulated over the entire period of
investigation and no change was observed for miR-16 and -206.
Bars represent mean ± SEM. * p < 0.05, ** p < 0.01, and *** p <
0.001 for each miRNA expression in axotomized group compared to
sham-operated control animals euthanized 24 h after surgery (time
0), n = 6 - 8 per group, Student’s t-test.
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sion of miR-16 and -206 (Figure 3B).
Acute noxious stimulation may also change gene expres-
sion, and therefore we evaluated the effect of capsaicin
stimulation on miRNAs regulation. Capsaicin was injected
at 2 or 10 μg/20 μl in order to investigate whether the sti-
mulus intensity correlates with a specific gene expression
pattern. Thus, capsaicin administration induced a concen-
tration-dependent nocifensive response when compared to
vehicle injected mice (Figure 4A). Moreover, capsaicin
induced a significant upregulation of miR-1 and miR-16,
but not miR-206, in DRG (Figure 4B). However, no differ-
ence was observed between the two concentrations
injected. On the other hand, no significant change was
observed in the spinal dorsal horn after injecting the lower
dose of capsaicin. In contrast, higher capsaicin dose
reduced only miR-206 expression (Figure 4C). Collectively,
these observations indicate that miRNA expression is
markedly modified by different pain conditions with a
high degree of spatial, temporal, and stimulus-dependent
specificity.
Discussion
Previous northern blot analysis showed that miR-1, -16
and -206 are expressed in mouse cortex, cerebellum e
midbrain [10,26]. Moreover, in silico studies predict that
those miRNAs plus miR-122a target several important
pain-related genes (Table 1). Our results indicate that
miR-1, -16, and -206, but not miR-122a are also
expressed in DRG and the dorsal horn of the spinal
cord. Moreover, the expression of these miRNAs in the
nociceptive system shows spatial and temporal specifi-
city, and a marked stimulus-dependent pattern of regu-
lation. Thus, while miRNA expression in DRG cells
promptly responded to nociceptive stimulation, the
spinal cord cells were less affected. A robust amount of
data have shown that various chronic pain conditions
result in a dramatic alteration of gene transcription and
protein synthesis in DRG, spinal cord dorsal horn and
brain nuclei [21,34,35]. These changes include both up
and downregulation of neuropeptides, G-protein
coupled receptors, growth factors and their receptors,
transcription factors as well as a large number of other
messenger molecules [21-23,36]. Although the mechan-
isms of transcriptional regulation in DRG and spinal
dorsal horn under nociceptive and pathological pain
remain largely unknown, our results strongly suggest an
important role for miRNAs in the activity-dependent
cellular plasticity underlying chronic pain. MiRNAs reg-
ulate protein synthesis through sequence-guided interac-
tions with the target complementary mRNA blocking
the transcription and translation processes [1,37]. There-
fore, changes on miRNA expression following nocicep-
tive stimulation may represent one of the earliest events
underlying the phenotypic switch induced by persistent
stimulation of nociceptive primary afferents, including
b o t hh i g ht h r e s h o l dC -a n dA δ-fibers. Over the last few
years there has been a rapid and an enormous progress
in cataloging hundreds of miRNA genes, determining
Figure 4 Effect of acute noxious stimulation on miRNA
expression in DRG and the dorsal horn of the spinal.( A)
Capsaicin induced a concentration-dependent nocifensive behavior
measured by the time spent licking the injected hindpaw. Control
group injected with vehicle showed no alteration on the behavior
response. (B) Ten minutes after stimulation, miR-1 (white bars) and
-16 (gray bars), but not miR-206 (black bars), showed an increased
expression in DRG, however, this upregulation was not
concentration-dependent as observed in the behavior test. (C)I n
the spinal dorsal horn, 2 μg of capsaicin had no effect on miRNAs
expression whereas 10 μg induced a dowregulation of miR-206. Bars
represent mean ± SEM. # p < 0.001 for comparing different
capsaicin-injected doses, * p < 0.05, ** p < 0.01, and *** p < 0.001
for capsaicin-injected animals compared to vehicle injected mice,
Mann-Whitney U test, n = 6 - 8,. Student’s t-test was used for gene
expression analysis where * p < 0.05, ** p < 0.01, and *** p < 0.001
for capsaicin-injected animals compared to vehicle injected mice,
n = 6 - 8 per group.
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their regulatory targets [38-40]. Notwithstanding, very
few data has been raised on the miRNA expression in the
nociceptive system. Bai and collaborators investigated the
expression of a number of miRNAs in rat trigeminal
ganglion (TG) during inflammatory muscle pain [18].
The authors investigated the time-course expression of
miR-10a, -29a, -98, -99a, -124a, -134, -183 following CFA
injection into the rat masseter muscle. All tested miRNAs
were significantly downregulated within 4 hr after CFA
administration whereas at day 12, all tested miRNAs
were completely recovered to a level similar to or higher
than the basal level. In our mouse model, CFA also
induced a sustained down regulation of miR-1 and -16
from 12 hours to 7 days post-injection in DRG. Interest-
ingly, Bai’s study reported a fluctuating pattern of expres-
sion for some miRNAs (e.g. miR-29a, and -134),
switching from downregulation to upregulation and
returning to the basal levels again. We have also observed
this dynamic pattern of expression in DRG following
CFA injection. Thus, miR-206 showed a significant
down-regulation on day 1 and 7, but not on day 3 post-
injection evidencing the same unsteady pattern of expres-
sion during CFA induced inflammation. Similarly to Bai,
we found no expression of miR-122, neither in DRG, nor
in the dorsal horn of the spinal cord. Moreover, none of
the stimuli applied were able to induce its expression.
Aldrich used the spinal nerve ligation model of chronic
neuropathic pain to investigate the expression of miR-
183 family members (miR-96, -182, and -183) in the rat
DRG [19]. The authors observed a significant reduction
in expression of these miRNAs in injured DRG neurons
2 weeks after nerve injury. Using the partial sciatic nerve
injury model we also observed a sustained downregula-
tion of miR-1 and -206, but not miR-16, in DRG. More-
over, there was no change on any miRNA in the spinal
dorsal horn. We extended the nerve injury assay to the
neuroma model of neuropathic pain. Interestingly, all
miRNA investigated showed a persistent upregulation in
DRG following axotomy whereas in the dorsal horn only
miR-1 was steadily downregulated. Together, our data
strongly reinforces the idea that miRNA expression in
the nociceptive system is stimulus-dependent. Recently,
the role of Dicer, a cytoplasmic ribonuclease III that gen-
erates miRNAs, in controlling inflammatory pain was
investigated. By deleting Dicer in DRG neurons expres-
sing the voltage-gated sodium channel Nav1.8 the authors
provided evidence that small double-stranded RNAs,
such as miRNAs, are important for regulating nocicep-
tor-associated mRNA transcripts. In addition, CFA-
induced mechanical allodynia and thermal hyperalgesia
were abolished in conditional mutant mice [20].
We have also addressed the question whether miRNAs
expression would be influenced by acute nociceptive sti-
mulation. Bai and collaborators have shown a significant
down-regulation of a number of miRNAs as early as
30 min after CFA injection [18]. We challenge this short-
time effect on miRNA expression by injecting capsaicin
into the dorsal aspect of the mouse hind paw. Capsaicin
immediately depolarizes primary afferent sensory neurons
through the transient receptor potential vanilloid type-1, a
non-selective cation channel [41]. Interestingly, 10 min
after capsaicin injection miR-1 and -16 were up-regulated
in DRG. A possible mechanism underlying this phenom-
enon might involve regulation of immediate-early genes
(IEGs), such as c-fos,c - jun and c-myc. These genes show
rapid and transient expression in the absence of de novo
protein synthesis [42-44]. In particular, c-fos,w h i c hi s
expressed at low levels in the intact brain under basal con-
ditions, is stereotypically induced in response to several
extracellular signals, including ions, neurotransmitters,
growth factors and drugs [45-47]. It is widely accepted
that regulatory IEGs are involved in the stimulus-
transcription coupling where c-fos has been considered a
generic marker of neuronal depolarization [48-51]. C-Fos
protein forms transcriptionally active dimmers with mem-
bers of the c-jun family, referred to as AP-1 transcription
factor. Recent data have associated miRNA activity with
Table 1 Pain-related target genes predicted for miR-1, -16, -122, and -206 from in silico analysis
Putative target NCBI reference microRNA PicTar score MicroCosm score TargetScan score Reference
Bdnf NM 007540 1, 16, 122, 206 12.6, 13.9, x, 8.7 x, x, 15.9, x -0.23, x, x, -0.23 [52-54]
Mapk3 NM 011952 1, 16, 122 x, 5.9, x x, x, 15.5 -0.21, x, x [55]
Calm2 NM 007589 1, 122, 206 5.6, 3.3, 6.6 -0.20, x, x [56,57]
Ngfr NM 033217 1, 206 -0.06, x, -0.06 [58-60]
Pla2g4a NM 008869 1, 206 17.4, 16.9 -0.34 [61-63]
Igf1 NM 010512 1, 206 3.1, 2.3 -0.47, x [64,65]
Trpc3 NM 019510 16 16.1 [66]
Oprd1 NM 013622 122 0.01 [67,68]
Genes, and the corresponding regulatory miRNAs predicted according to PicTar (27), MicroCosm Target version 5 (internet available at http://www.ebi.ac.uk/
enright-srv/microcosm), and TargetScan (28) databases. For each predicted gene the NCBI number, predicted microRNA, PicTar score, MicroCosm score,
TargetScan score, and pain-related references are provided. Larger PicTar scores, higher MicroCosm scores, and more negative TargetScan scores indicate high-
likelihood of encoding a target containing conserved 3’ UTR sequences; x corresponds to non-identified target in the database.
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importance of AP-1 as potent transcriptional activator, it
is reasonable to speculate that various mechanisms would
have evolved to regulate its activity, including miRNA
activity. We were also interested in investigating whether
miRNA expression would be dependent on stimulus
intensity. Behaviorally, capsaicin administration induces a
pronounced nocifensive response in a concentration-
dependent manner. However, the enhanced miRNA
expression in DRG did not show any association between
stimulus intensity and expression pattern suggesting a ceil-
ing effect. Conversely, in the spinal dorsal horn 10 μg, but
not 2 μg, of capsaicin induced a significant downregulation
of miR-206 indicating that miRNAs may also be activated
in a stimulus intensity-dependent fashion.
Conclusions
In summary, our data shows that miRNAs are differen-
tially regulated under chronic and acute pain states. We
speculate that miRNAs may be involved in the mechan-
isms underlying different pain conditions by fine-tuning
the expression of pro and/or antinociceptive molecules.
Whether these miRNAs activity is associated with the
mechanisms underlying inflammatory and neuropathic
pain cannot be addressed by the present study. The
answer to this important question relies primarily on
the elucidation of their target mRNAs. However,
miRNA may integratedly modulate several genes asso-
ciated with both the nociceptive and analgesic systems,
influencing the dramatic neuronal changes responsible
for the development and maintenance of chronic pain
conditions. Most important, miRNA expression in the
nociceptive system shows not only spatiotemporal speci-
ficity but is also stimulus-dependent.
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